Hepatic Steatosis and Subclinical Cardiovascular Disease in a Cohort Enriched for Type 2 Diabetes: The Diabetes Heart Study
- 1 December 2008
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 103 (12) , 3029-3035
- https://doi.org/10.1111/j.1572-0241.2008.02188.x
Abstract
OBJECTIVES: To explore mechanisms whereby hepatic steatosis may be associated with cardiovascular risk, we investigated cross-sectional relationships between hepatic steatosis, regional fat accumulation, inflammatory biomarkers, and subclinical measures of atherosclerosis in the Diabetes Heart Study. METHODS: The Diabetes Heart Study is a family study of sibling pairs concordant for type 2 diabetes. A subset of 623 randomly selected participants was evaluated for hepatic steatosis, defined as a liver:spleen attenuation ratio of < 1.0 by computed tomography. We quantified visceral fat, subcutaneous fat, coronary, aortic, and carotid artery calcium by computed tomography; and carotid atherosclerosis by ultrasound. Associations between the liver:spleen attenuation ratio and these factors were expressed as Spearman correlations. RESULTS: After adjustment for age, race, gender, body mass index, and diabetes status, the liver:spleen attenuation ratio correlated with visceral fat (r = -0.22, P < 0.0001) and subcutaneous fat (r = -0.13, P = 0.031). Hepatic steatosis was associated with lower high-density lipoprotein (r = 0.21, P < 0.0001), higher triglycerides (r = -0.25, P < 0.0001), higher C-reactive protein (r = -0.095, P = 0.004), and lower serum adiponectin (r = 0.34, P < 0.0001). There were no significant associations between the liver:spleen attenuation ratio and coronary, aortic, or carotid calcium, or carotid intimal thickness. CONCLUSIONS: This suggests that hepatic steatosis is less likely a direct mediator of cardiovascular disease and may best be described as an epiphenomenon. The strong correlations between pro-atherogenic biomarkers, visceral fat, and elements of the metabolic syndrome suggest that hepatic steatosis reflects more than general adiposity, but represents a systemic, inflammatory, pro-atherogenic adipose state. (Am J Gastroenterol 2008;103:3029-3035).Keywords
This publication has 25 references indexed in Scilit:
- A Comparison of Risk Factors for Calcified Atherosclerotic Plaque in the Coronary, Carotid, and Abdominal Aortic Arteries: The Diabetes Heart StudyAmerican Journal of Epidemiology, 2007
- Comparison of CT Methods for Determining the Fat Content of the LiverAmerican Journal of Roentgenology, 2007
- Pathogenesis of Non-alcoholic Steatohepatitis: Human DataClinics in Liver Disease, 2007
- Performance of Subclinical Arterial Disease Detection as a Screening Test for Coronary Heart DiseaseHypertension, 2006
- Non‐alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non‐diabetic men. Role of visceral adipose tissueDiabetic Medicine, 2005
- Nonalcoholic Fatty Liver Disease Is Associated With Carotid AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Relation of family history of premature coronary heart disease and metabolic risk factors to risk of coronary arterial calcium in asymptomatic subjectsThe American Journal of Cardiology, 2005
- Race-Specific Relationships Between Coronary and Carotid Artery Calcification and Carotid Intimal Medial ThicknessStroke, 2004
- Heritability of Carotid Artery Intima-Medial Thickness in Type 2 DiabetesStroke, 2002
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986